|Cost analyses of vaccination programs in the general population|
|First author [Reference]||Gudnadottir []||Fontanesi []||Haas []|
|WB income group||High||High||High|
|Group targeted||Children||Children||Pregnant women|
|Comparators||1. Vaccinate all children and re-vaccinate women||1. MMR vaccination||1. Rubella test and rubella vaccine|
|2. Vaccinate girls and sero-negative women||2. DTaP vaccination||2. Rubella test and MMR vaccine|
|3. Vaccinate all children and re-vaccinate girls||3. IPV vaccination||3. MMR test and MMR vaccine|
|4. Vaccinate screened women||4. MMR test and rubella/MMR vaccine|
|Cost components measured||Vaccine; serology||Vaccine; personnel; syringes||Vaccine; serology|
|Method of cost estimation||Micro-costing||Micro-costing||Micro-costing|
|Time period for costing||One-time vaccination at different ages||One-time vaccination (complete number of doses)||One-time vaccination|
|Results (2012 US$)||1. $1,063||1. $30||1. $8|
|2. $638||2. $23||2. $10|
|3. $2,409||3. $18||3. $37|
|4. $283||4. $35|
|Stated conclusion||Vaccination of girls and of women after screening was preferable||The MMR vaccine had the highest cost per immunized child||The combined MMR test and vaccination was the most costly|
|Sponsor||Iceland MOHSS||US CDC||NMBS|
*Not explicitly reported but inferred.
WB, World Bank; NR, Not Reported; NA, Not Applicable; MOHSS, Ministry of Health and Social Services; MMR, Measles Mumps Rubella; DTaP, Diptheria Mumps Rubella; IPV, Inactivated Polio Vaccine; CDC, Centers for Disease Control; NMBS, Navy Bureau of Medicine and Surgery.
Babigumira et al.
Babigumira et al. BMC Public Health 2013 13:406 doi:10.1186/1471-2458-13-406